| Epidemiological and molecular surveillance of multiresistant Citrobacter freundii complex in a tertiary care hospital : A retrospective cohort study | The Journal of infectious diseases |  | | 2026 | 43 | 100 |
|
| Increased incidence of blood culture contaminations during and after the COVID-19 pandemic | Infection | | | 2025 | 47 | 252 |
|
| Horizontal transmission of a multidrug-resistant IncM1 plasmid harbouring blaOXA-48 and blaCTX-M-14b among patient microbiotas | The journal of antimicrobial chemotherapy | | | 2025 | 65 | 201 |
|
| Combined resistance mechanisms leading to high-level of cefiderocol resistance among NDM-like producing E. coli ST167 clinical isolates | European journal of clinical microbiology & infectious diseases | | | 2025 | 17 | 104 |
|
| Epidémiologie, facteurs de risque et outcomes des bactériémies pendant la période d’aplasie chez les receveurs de greffe de cellules souches hématopoïétiques | | | | 2025 | 102 | 630 |
|
| Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland | Infection | | | 2025 | 41 | 232 |
|
| Increase in PVC-BSI during the second COVID-19 pandemic year : analysis of catheter and patient characteristics | Antimicrobial resistance and infection control | | | 2024 | 64 | 132 |
|
| Microbiology of catheter associated bloodstream infection : differences according to catheter type | International journal of infectious diseases | | | 2024 | 59 | 246 |
|
| In-vitro activity of the novel β-lactam/β-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022 | European journal of clinical microbiology & infectious diseases | | | 2024 | 65 | 191 |
|
| Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates | Clinical microbiology and infection |  | | 2024 | 113 | 1 |
|
| Impact of intermittent versus continuous infusions on central line-associated bloodstream infection risk in haemato-oncology patients : a quasi-experimental study | The Journal of hospital infection | | | 2024 | 62 | 363 |
|
| Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis | Transplant infectious disease | | | 2024 | 67 | 183 |
|
| Controlling the hospital aquatic reservoir of multidrug-resistant organisms : a cross-sectional study followed by a nested randomized trial of sink decontamination | Clinical microbiology and infection | | | 2024 | 171 | 208 |
|
| Postpartum septic arthritis of pubic symphysis due to Sneathia sanguinegens, Sneathia vaginalis, and Mageeibacillus indolicus : Contribution of clinicalmetagenomics | New microbes and new infections | | | 2023 | 257 | 234 |
|
| Increased Peripheral Venous Catheter Bloodstream Infections during COVID-19 Pandemic, Switzerland | Emerging infectious diseases | | | 2023 | 128 | 495 |
|
| Hepatitis C treatment program in Maputo, Mozambique, the challenge of genotypes and key populations : A 5-year retrospective analysis of routine programmatic data | Health science reports | | | 2023 | 103 | 79 |
|
| Epidemiological characteristics and real-world treatment outcomes of hepatitis C among HIV/HCV co-infected patients in Myanmar : A prospective cohort study | Health science reports | | | 2023 | 78 | 109 |
|
| Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services, Mozambique | Bulletin of the World Health Organization | | | 2022 | 76 | 131 |
|
| Letermovir for cytomegalovirus primary prophylaxis in a multiple abdominal/small bowel transplant recipient | Clinical transplantation | | | 2022 | 260 | 0 |
|
| Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar | BMJ global health | | | 2021 | 88 | 72 |
|
| Fièvre d’origine indéterminée : cheval, zèbre ou licorne ? | Revue médicale suisse | | | 2021 | 100 | 548 |
|
| HCV genetic diversity can be used to infer infection recency and time since infection | Viruses | | | 2020 | 236 | 124 |
|
